Active ingredient
Mosunetuzumab
4 finished FDA listings contain Mosunetuzumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- MOSUNETUZUMAB
- Dosage forms
- Concentrate, Injection
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 1 mg/ml · 30 mg/30ml · 45 mg/ml · 5 mg/.5ml
- Brand names in FDA listings
- Lunsumio, Lunsumio Velo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2625122
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761263 | GENENTECH INC | 2022-12-22 | 4 |
Official labeling on DailyMed
- LUNSUMIO VELO (MOSUNETUZUMAB) INJECTION [GENENTECH, INC.] · version 4 · 2026-07-02
- LUNSUMIO (MOSUNETUZUMAB) CONCENTRATE [GENENTECH, INC.] · version 7 · 2026-06-30
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.